Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment. - Laboratoire d'Analyse et de Mathématiques Appliquées Accéder directement au contenu
Article Dans Une Revue Oncogene Année : 2006

Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment.

Résumé

We have studied the role of cyclins and cyclin-dependent kinase (CDK) activity in apoptosis induced by camptothecin (CPT). In this model, 22% of the cells stain for annexin-V at 24 h and then proceed to be 93% positive by 72 h. This time window permits the analysis of cyclins in cells that are committed to apoptosis but not yet dead. We provide evidence that cyclin protein levels and then associated kinase levels increase after CPT treatment. Strikingly, cyclin B1 and cyclin E1 proteins are present at the same time in CPT treated HT29 cells. Although cyclin B1 and E1 CDK complexes are activated in CPT treated cells, only the cyclin B1 complex is required for apoptosis since reduction of cyclin B1 by RNAi or roscovitine treatment reduces the number of annexin-V-stained cells. We have detected poorly organized chromosomes and phosphorylated histone H3 epitopes at the time of maximum cyclin B1/CDK kinase activity in CPT-treated cells, which suggests that these cells enter a mitotic catastrophe. Understanding which CDKs are required for apoptosis may allow us to better adapt CDK inhibitors for use as anti-cancer compounds.
Fichier non déposé

Dates et versions

hal-00169380 , version 1 (03-09-2007)

Identifiants

Citer

A. Borgne, I. Versteege, M. Mahé, A. Studeny, S. Léonce, et al.. Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment.. Oncogene, 2006, 25 (56), pp.7361-72. ⟨10.1038/sj.onc.1209718⟩. ⟨hal-00169380⟩
220 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More